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LETTERS
Probable  
Importation of  
Dengue Virus  
Type 4 to Angola 
from Brazil
To the Editor: The prevalence 
of dengue virus (DENV) infection in 
Africa may have been grossly under-
estimated for many years (1). Even 
though published reports are scarce, 
dengue has been documented in at 
least 34 countries in Africa (2). The 
role of travelers as sentinels of infec-
tious disease has proven to be invalu-
able in this regard; dengue in return-
ing travelers was the only evidence 
for local DENV transmission for 12 of 
these countries.
During April 2013, simultaneous 
reports of travelers returning from 
Luanda, Angola, with dengue fever 
emerged from Israel, several countries 
in Europe, Canada, and South Africa; 
PCR and sequencing of viral RNA 
confirmed the causative species to be 
DENV type 1 (DENV-1) (3). Con-
comitantly, a large outbreak of dengue 
was confirmed by local authorities in 
Luanda, and DENV-1 was isolated in 
samples from local residents (4). The 
origin of the outbreak strain was not 
ascertained, but phylogenetic analy-
sis suggested that it had close affinity 
with isolates from West Africa (4,5). 
These reports involved almost 100 
travelers and >500 residents of Lu-
anda who become within a short time. 
Active DENV transmission and oc-
currence of new cases in Luanda were 
still ongoing during early July 2013 
(6), but since then, to our knowledge, 
no additional local data on DENV ac-
tivity in Luanda have been published.
We report 3 new cases of den-
gue fever acquired in Luanda dur-
ing December 2013–February 2014. 
Two cases occurred in travelers who 
returned to Israel, and 1 occurred in 
a traveler who returned to Germany. 
All 3 cases occurred in middle-aged 
businessmen who had traveled to 
Angola and who were hospitalized 
within days of returning to their home 
countries because of signs and symp-
toms of dengue fever. None of the 
case-patients met criteria for severe 
dengue, and all recovered unevent-
fully. Acute DENV infection was 
confirmed by serologic testing in all 
3 patients and by positive results for a 
nonstructural protein 1 serum antigen 
test in 2 travelers.
In a serum sample taken from 1 
of the travelers from Israel on the sec-
ond day of fever, DENV RNA was de-
tected by using reverse transcription 
PCR. This strain was found to belong 
to DENV type 4 (DENV-4). Phylo-
genetic analysis was performed, and 
multiple sequence alignment of this 
DENV-4 sequence, in comparison to 
other DENV-4 sequences retrieved 
from GenBank, was performed by 
using the Sequencher 5.0 program 
(Gencodes Corporation, Ann Arbor, 
MI, USA). A maximum-likelihood 
phylogenetic tree was inferred from 
the sequence alignment by using 
ClustalX (http://www.clustal.org), 
and the robustness of the tree was 
assessed by 1,000 bootstrap replica-
tions. The tree was visualized and 
produced by using NJ plot software 
(http://doua.prabi.fr/software/njplot). 
Results showed that RNA from this 
isolate was most closely related to 
that of a DENV-4 strain identified in 
2010 in Boa Vista, the capital of Ro-
raima State in the Amazon Region of 
Brazil (7) (Figure).
DENV-4 infection was previ-
ously reported in Africa in 1986, when 
2 cases were identified in travelers 
returning from Senegal (8), but to 
our knowledge, no other cases have 
been reported in western or south-
western Africa. During the April 2013 
dengue outbreak in Luanda, only 
DENV-1 was isolated (3,4). After 
that outbreak, a study conducted on 
the basis of modeling of international 
commercial flight data to and from 
Angola suggested that DENV would 
most likely have been imported from 
Latin America (5). Our finding, a year 
later, of DENV-4 in Angola that was 
closely related to strains from Brazil 
appears to vindicate this modeling 
system. During the past decade, Bra-
zil had been experiencing a consistent 
increase in dengue epidemics and in 
severity of disease (9). Brazil’s large 
and growing economy, its increas-
ingly prominent place in world trade, 
and its growing tourism industry high-
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light the country’s potential role in the 
global circulation of DENV.
Our findings are corroborated by 
a recently reported case of dengue in 
a traveler from Portugal that was ac-
quired in Luanda concomitantly with 
our cases and also found to be caused 
by DENV-4 (10). In light of the ap-
parent introduction of DENV-4 to 
Angola, probably from Brazil, health 
authorities should be encouraged to 
enhance surveillance and vector con-
trol efforts. In addition, health prac-
titioners treating travelers returning 
from Angola should be aware of the 
risk for DENV infection.
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Borrelia garinii  
and Rickettsia  
monacensis in  
Ixodes ricinus 
Ticks, Algeria
To the Editor: Lyme disease 
(Lyme borreliosis) is caused by a 
group of related spirochetes (Borrelia 
burgdorferi sensu lato) that include 
≥11 species (1). In northern Africa, 
the main vector of Lyme disease in 
Europe (Ixodes ricinus ticks) is also 
present, and this disease has been sus-
pected to be present in this region of 
Africa (2). Twenty-one cases of Lyme 
disease were reported in Algiers, Al-
geria, during 1996–1999 (3). How-
ever, these cases were diagnosed by 
detection of only serum antibodies 
against B. burgdorferi by ELISA with-
out confirmation by Western blotting.
I. ricinus ticks are also known 
to harbor spotted fever group rickett-
siae, including Rickettsia monacensis, 
which was detected in Algeria in 2009 
(4). This rickettsia has been recently 
identified as a human pathogen in 
Spain and Italy (5).
To investigate Lyme disease and 
tickborne rickettsioses transmitted by 
I. ricinus ticks in northeastern Alge-
ria, we collected ticks by using the flag 
method in El Ghora (Bougous, El Tarf) 
(36°39′34″N, 8°22′10″E). Ectopara-
sites were collected in March 2012 and 
identified to genus and species by using 
taxonomic morphologic keys (6).
Total genomic DNA was isolated 
by using the QIAamp Tissue Kit (QIA-
GEN, Hilden, Germany) and BioRobot 
EZ1 (QIAGEN) as described by the 
manufacturer. DNA was used as tem-
plate for quantitative real-time PCR. 
We used the RKND03 system, which is 
specific for the gltA gene of Rickettsia 
spp. (7), and the Bor16S system, which 
is specific for the rrs gene of Borrelia 
spp. (8). Real-time PCRs were per-
formed by using the CFX96 Real Time 
System C1000 Touch Thermal Cycler 
(Bio-Rad Laboratories, Singapore).
1776	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	10,	October	2014
1These	 authors	 contributed	 equally	 to	 this	
article.
GovDelivery
Manage your email alerts so you only
receive content of interest to you.
Sign up for an Online Subscription:
wwwnc.cdc.gov/eid/subscribe.htm
Table of Contents  
Emailed to you
